Fingerprint
Dive into the research topics of 'What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
What is the optimal time to initiate hypomethylating agents (HMAs) in higher risk myelodysplastic syndromes (MDSs)?
Rami Komrokji, Najla Al Ali, Eric Padron, Jeffrey Lancet, Aziz Nazha, David Steensma, Amy DeZern, Gail Roboz, Guillermo Garcia-Manero, Mikkael A. Sekeres, David Sallman
Research output: Contribution to journal › Article › peer-review